| 著者 |
Ménard-Moyon, Cécilia
CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS
Nishina, Yuta
Research Institute for Interdisciplinary Science, Okayama University
ORCID
Kaken ID
publons
researchmap
Bianco, Alberto
Research Institute for Interdisciplinary Science, Okayama University
|
| 抄録 | Graphene oxide (GO) has emerged as one of the most extensively studied two-dimensional (2D) materials, thanks to its large surface area and abundance of functional groups, which enable applications across energy, catalysis, electronics, construction, and mobility. Its exceptional dispersibility in water further expands its use in the biomedical field. However, researchers have consistently expressed concerns about the limited control over GO chemical composition and structural heterogeneity. These factors are often overlooked, strongly affecting the reproducibility in both synthesis and applications. Because GO is considered a promising platform for advanced drug delivery, achieving reproducible preparation and precise structural control is essential to make it a reliable alternative to the many nanomaterials currently being explored for nanomedicine.
Motivated by these challenges, we have focused our work on identifying and controlling the key parameters that govern GO structure and surface chemistry. Over the past decade, we have developed methods to produce GO with controlled and tunable chemical structures, clarified the reactivity of its major functional groups, and developed robust strategies for postfunctionalizing GO with therapeutic agents, targeting ligands, and imaging dyes. In parallel, we have established systematic approaches to evaluate GO biocompatibility and biodegradability, revealing how specific physicochemical features influence biological responses and clearance pathways. Together, these findings provide a unified framework linking GO synthesis, chemical modification, and biological behavior. By integrating chemical control, functional performance, and safety assessment, our work outlines a coherent strategy for the rational design of GO-based biomedical materials. We believe that this Account offers a solid foundation for the targeted exploitation of GO in nanomedicine and will help facilitate its eventual clinical translation. |
| 備考 | This document is the Accepted Manuscript version of a Published Article that appeared in final form in Accounts of Materials Research, copyright © 2026 The Authors. . To access the final published article, see ACS Articles on Request.
This fulltext file will be available in Apr. 2027.
|
| 発行日 | 2026-04-03
|
| 出版物タイトル |
Accounts of Materials Research
|
| 巻 | 7巻
|
| 号 | 4号
|
| 出版者 | American Chemical Society (ACS)
|
| 開始ページ | 399
|
| 終了ページ | 409
|
| ISSN | 2643-6728
|
| 資料タイプ |
学術雑誌論文
|
| 言語 |
英語
|
| OAI-PMH Set |
岡山大学
|
| 著作権者 | © 2026 The Authors.
|
| 論文のバージョン | publisher
|
| DOI | |
| Web of Science KeyUT | |
| 関連URL | isVersionOf https://doi.org/10.1021/accountsmr.5c00362
|
| Citation | Cécilia Ménard-Moyon, Yuta Nishina, Alberto Bianco; Graphene Oxide: Designing a Functional Smarter Material for Advanced Biomedicine. Acc. Mater. Res. 24 April 2026; 7 (4): 399–409. https://doi.org/10.1021/accountsmr.5c00362
|
| 助成情報 |
JPMJCR24S6:
( 国立研究開発法人科学技術振興機構 / Japan Science and Technology Agency )
( Centre National de la Recherche Scientifique )
( Jean Marie Lehn Foundation )
( SysChem )
|